Sharecafe

Argenica Therapeutics (ASX: AGN) – Webinar Presentation

Liz Dallimore - CEO & Managing Director - Argenica Therapeutics is developing novel neuroprotective therapeutics to reduce brain damage after stroke.

Liz Dallimore – CEO & Managing Director – Argenica Therapeutics is developing novel neuroprotective therapeutics to reduce brain damage after stroke.

Serving up fresh finance news, marker movers & expertise.
LinkedIn
Email
X

All Categories